Clinical Trial Update: Phase I Study to Evaluate KP405 in Healthy and Parkinson's Disease Patients [EARLY_Phase 1]

View source ↗

Summary

A Phase I study evaluating KP405 in healthy volunteers and Parkinson's disease patients is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• KP405

Snippet

Sponsor: Kariya Pharmaceuticals | Conditions: Safety Issues, Tolerance | EARLY_Phase 1 | Status: RECRUITING